# Michigan Treasury Issues New 24% Wholesale Marijuana Tax Guidance > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/2026-cannabis-wholesale-tax-impact-michigan/ > **Published:** 2026-03-23T12:01:39-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T10:41:41-04:00 > **Clinical Summary:** Explore the 2026 cannabis wholesale tax impact in Michigan and its effects on medical cannabis pricing and patient access. --- ✦ New CED Clinical Relevance  #70Notable Clinical Interest  Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News  |  CED Clinic Healthcare AccessPolicy[Medical Cannabis](https://cedclinic.com/therapeutic-benefits-of-thc/)Treatment AdherenceHealthcare Economics Why This Matters Tax policy changes directly impact patient access to [medical cannabis](https://cedclinic.com/therapeutic-benefits-of-thc/), as increased wholesale costs typically translate to higher retail prices. For clinicians treating patients with cannabis, understanding local tax structures helps anticipate affordability barriers that may affect treatment adherence and outcomes. Clinical Summary Michigan has implemented new guidance for a 24% wholesale marijuana tax structure. While specific implementation details aren’t provided in the summary, wholesale tax increases generally create downstream price pressures on both medical and recreational cannabis products. Tax policy represents a significant cost component in cannabis pricing, often accounting for 20-40% of final retail prices depending on jurisdiction. Dr. Caplan’s Take “I regularly see patients discontinue effective cannabis treatments due to cost barriers, and tax policy is often the invisible driver behind those decisions. When states increase wholesale taxes, I have to factor affordability into treatment planning just as I would with any other medication.” Clinical Perspective 🧠 Clinicians should anticipate potential patient concerns about treatment costs following this tax implementation. Consider discussing generic alternatives, dosing optimization for cost-effectiveness, and state medical cannabis programs that may offer tax exemptions or reduced rates for qualified patients. 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/forum/cannabis-industry/) Have thoughts on this? Share it: [𝕏 Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20Michigan%20Treasury%20releases%20guidance%20on%20new%2024%25%20wholesale%20marijuana%20tax%20%40drcaplan&url=https%3A//www.thealpenanews.com/news/2026/03/michigan-treasury-releases-guidance-on-new-24-wholesale-marijuana-tax/)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A//www.thealpenanews.com/news/2026/03/michigan-treasury-releases-guidance-on-new-24-wholesale-marijuana-tax/)[🦥 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20Michigan%20Treasury%20releases%20guidance%20on%20new%2024%25%20wholesale%20marijuana%20tax%20--%20via%20%40drcaplan.bsky.social%20https%3A//www.thealpenanews.com/news/2026/03/michigan-treasury-releases-guidance-on-new-24-wholesale-marijuana-tax/)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/)[📝 Read more on Substack](https://substack.com/@doctorapproved)[🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/) 📰 Source: [https://www.thealpenanews.com/news/2026/03/michigan-treasury-releases-guidance-on-new-24-wholesale-marijuana-tax/](https://www.thealpenanews.com/news/2026/03/michigan-treasury-releases-guidance-on-new-24-wholesale-marijuana-tax/) Table of Contents - [FAQ](#FAQ)[What is the clinical relevance rating of this cannabis news?](#What_is_the_clinical_relevance_rating_of_this_cannabis_news) - [What healthcare topics does this article cover?](#What_healthcare_topics_does_this_article_cover) - [Who would benefit from reading this cannabis news update?](#Who_would_benefit_from_reading_this_cannabis_news_update) - [What type of cannabis-related content can be expected?](#What_type_of_cannabis-related_content_can_be_expected) - [Why is treatment adherence highlighted as a key topic?](#Why_is_treatment_adherence_highlighted_as_a_key_topic) - [Related](#Related) ## FAQ #### What is the clinical relevance rating of this cannabis news? This article has been assigned CED Clinical Relevance #70, indicating “Notable Clinical Interest.” This rating suggests the content contains emerging findings or policy developments that healthcare professionals should monitor closely. #### What healthcare topics does this article cover? The article focuses on healthcare access, policy developments, and medical cannabis. It also addresses treatment adherence issues related to [cannabis-based therapies](https://cedclinic.com/cannabinoids-inhibit-keratinocyte-proliferation-non-cb1-cb2/). #### Who would benefit from reading this cannabis news update? Healthcare professionals, particularly those involved in [cannabis medicine](https://cedclinic.com/essential-oils-industrial-hemp-antimicrobial-benefits/), would find this valuable. Clinicians interested in policy changes affecting patient access to medical cannabis treatments should monitor these developments. #### What type of cannabis-related content can be expected? This appears to be a policy-focused update from CED Clinic regarding [medical cannabis access](https://cedclinic.com/medical-marijuana-card-reciprocity/) and treatment protocols. The content likely discusses regulatory changes or clinical practice developments in the [cannabis medicine](https://cedclinic.com/essential-oils-industrial-hemp-antimicrobial-benefits/) field. #### Why is treatment adherence highlighted as a key topic? Treatment adherence is crucial in medical [cannabis therapy](https://cedclinic.com/cannabis-based-therapies-smoking-cessation/) for achieving optimal patient outcomes. Policy changes and healthcare access improvements can significantly impact how well patients maintain their prescribed cannabis treatment regimens. {“@context”: “https://schema.org”, “@type”: “NewsArticle”, “headline”: “Michigan Treasury releases guidance on new 24% wholesale marijuana tax”, “url”: “https://www.thealpenanews.com/news/2026/03/michigan-treasury-releases-guidance-on-new-24-wholesale-marijuana-tax/”, “datePublished”: “2026-03-23T11:33:51Z”, “about”: “michigan treasury releases guidance new 24”} [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [US (RI): Battle rages over adult-use cannabis stores](https://cedclinic.com/rhode-island-cannabis-licenses-adult-use-market-challenges/) Explore ongoing regulatory challenges in Rhode Island's adult-use cannabis market and their implications for access and policy. [Read More](https://cedclinic.com/rhode-island-cannabis-licenses-adult-use-market-challenges/) [NC Cannabis Advisory Council interim report recommends adult-use recreational program](https://cedclinic.com/north-carolina-adult-use-cannabis-program-interim-report/) Review North Carolina's advisory council recommendations on adult-use cannabis programs and their potential policy impact. [Learn More](https://cedclinic.com/north-carolina-adult-use-cannabis-program-interim-report/) [Retail cannabis applicants vent after ruling stalls an already 'slow as molasses' license rollout](https://cedclinic.com/cannabis-retail-licensing-delays-stall-patient-access/) Understand the frustrations and delays faced by retail cannabis applicants amid regulatory rulings affecting license rollouts. [Discover More](https://cedclinic.com/cannabis-retail-licensing-delays-stall-patient-access/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Former CMO Canna Care Docs (250,000+ patients supervised), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).